Recap: Fulgent Genetics Q2 Earnings - Fulgent Genetics (NASDAQ:FLGT)

Fulgent Genetics FLGT reported its Q2 earnings results on Thursday, August 4, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Fulgent Genetics beat estimated earnings by 6.85%, reporting an EPS of $0.78 versus an estimate of $0.73.

Revenue was down $28.27 million from the same period last year.

Last quarter the company beat on EPS by $1.22 which was followed by a 3.6% increase in the share price the next day.

Here's a look at Fulgent Genetics's past performance:

Quarter	Q1 2022	Q4 2021	Q3 2021	Q2 2021
EPS Estimate	3.86	2.61	3.25	2.81
EPS Actual	5.08	3.48	4.05	2.55
Revenue Estimate	270.85M	191.10M	264.00M	197.34M
Revenue Actual	320.27M	251.67M	227.87M	153.62M

To track all earnings releases for Fulgent Genetics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.